4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-054327
Chief Operating Officer sold 3,000 shares at an average $47.26 ($141,778)
- Chief Operating Officer acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim Chief Operating Officer | 2023-11-01 | Option exercise 10b5-1 | +3,000 | $2.42 | $7,260 | 178,935 | D |
| Wassil Jim Chief Operating Officer | 2023-11-01 | Sale 10b5-1 | −2,878 | $47.22 | $135,908 | 176,057 | D |
| Wassil Jim Chief Operating Officer | 2023-11-01 | Sale 10b5-1 | −122 | $48.12 | $5,871 | 175,935 | D |
| Derivatives | |||||||
| Wassil Jim Chief Operating Officer | 2023-11-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 99,555 | D | ||
| Open-market sales · 3,000 sh · avg $47.26 · $141,778 | |||||||
Loading xslF345X05/doc4.xml…